Citations (78)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Huilan Li, Yuanying Fang, Shuchun Guo & Zunhua Yang. (2021) GPR119 agonists for the treatment of type 2 diabetes: an updated patent review (2014-present). Expert Opinion on Therapeutic Patents 31:9, pages 795-808.
Read now
Read now
André J. Scheen. (2016) Investigational insulin secretagogues for type 2 diabetes. Expert Opinion on Investigational Drugs 25:4, pages 405-422.
Read now
Read now
Joseph W. Polli, Elizabeth Hussey, Mark Bush, Grant Generaux, Glenn Smith, David Collins, Susan McMullen, Nancy Turner & Derek J. Nunez. (2013) Evaluation of drug interactions of GSK1292263 (a GPR119 agonist) with statins: from in vitro data to clinical study design. Xenobiotica 43:6, pages 498-508.
Read now
Read now
Lauren M Cornall, Michael L Mathai, Deanne H Hryciw & Andrew J McAinch. (2013) Is GPR119 agonism an appropriate treatment modality for the safe amelioration of metabolic diseases?. Expert Opinion on Investigational Drugs 22:4, pages 487-498.
Read now
Read now
Anders Tengholm. (2012) Cyclic AMP dynamics in the pancreatic β-cell. Upsala Journal of Medical Sciences 117:4, pages 355-369.
Read now
Read now
Articles from other publishers (73)
Priyanshu Nema, Vivek Asati, Priyadarshi Kendya, Twinkle Gupta, Shivangi Agarwal, Shivam Kori, Varsha Kashaw, Arun K. Iyer & Sushil Kumar Kashaw. (2023) Structural Insight on GPR119 Agonist as Potential Therapy for Type II
Diabetes: A Comprehensive Review. Mini-Reviews in Medicinal Chemistry 23:21, pages 2008-2040.
Crossref
Crossref
Anuradha Mehra, Rekha Sangwan, Aryan Mehra, Shivani Sharma, Pankaj Wadhwa & Amit Mittal. (2023) Therapeutic charisma of imidazo [2,1-b] [1,3,4]-thiadiazole analogues: a patent review. Pharmaceutical Patent Analyst.
Crossref
Crossref
Zekun Lyu, Min Zhao, Patricio Atanes & Shanta Jean Persaud. (2022) Quantification of changes in human islet G protein‐coupled receptor mRNA expression in obesity. Diabetic Medicine 39:12.
Crossref
Crossref
Jianan Zhao, Yu Zhao, Yiyang Hu & Jinghua Peng. (2021) Targeting the GPR119/incretin axis: a promising new therapy for metabolic-associated fatty liver disease. Cellular & Molecular Biology Letters 26:1.
Crossref
Crossref
Silvano Paternoster, Peter V. Simpson, Elena Kokh, Hüsün Sheyma Kizilkaya, Mette Marie Rosenkilde, Ricardo L. Mancera, Damien J. Keating, Massimiliano Massi & Marco Falasca. (2021) Pharmacological and structure-activity relationship studies of oleoyl-lysophosphatidylinositol synthetic mimetics. Pharmacological Research 172, pages 105822.
Crossref
Crossref
Ajay Manaithiya, Ozair Alam, Vrinda Sharma, Mohd. Javed Naim, Shruti Mittal & Imran A Khan. (2021) GPR119 agonists: Novel therapeutic agents for type 2 diabetes mellitus. Bioorganic Chemistry 113, pages 104998.
Crossref
Crossref
Prateek Sharma, Sukhbir Singh, Vinay Thakur, Neelam Sharma & Ajmer Singh Grewal. (2021) Novel and emerging therapeutic drug targets for management of type 2 Diabetes Mellitus. Obesity Medicine 23, pages 100329.
Crossref
Crossref
Amit Gupta, Tapan Behl, Aayush Sehgal, Shaveta Bhardwaj, Sukhbir Singh, Neelam Sharma & Abdul Hafeez. (2021) Exploring the recent molecular targets for diabetes and associated complications. Molecular Biology Reports 48:3, pages 2863-2879.
Crossref
Crossref
Sarbani Pal & Manojit Pal. 2021. Drug Discovery and Drug Development. Drug Discovery and Drug Development
179
212
.
Junfang Jia, Yun Chen, Lin Xu, Yun Yang, Xingxing Xu, Hongyu Ding, Caiwei Jia, Hong Gao, Pengxiang Guo & Ronggui Hu. (2020) Screening for bacterial enzymes synthesizing GPR119 agonist in cAMP-responsive cells. Acta Biochimica et Biophysica Sinica.
Crossref
Crossref
Zhiwei Zeng, Shi-Ying Huang & Tao Sun. (2020) Pharmacogenomic Studies of Current Antidiabetic Agents and Potential New Drug Targets for Precision Medicine of Diabetes. Diabetes Therapy 11:11, pages 2521-2538.
Crossref
Crossref
Punn Augsornworawat, Kristina G. Maxwell, Leonardo Velazco-Cruz & Jeffrey R. Millman. (2020) Single-Cell Transcriptome Profiling Reveals β Cell Maturation in Stem Cell-Derived Islets after Transplantation. Cell Reports 32:8, pages 108067.
Crossref
Crossref
A. A. Spasov, V. S. Lobasenko, V. A. Kosolapov, D. A. Babkov, V. A. Kuznetsova, O. Yu. Maika, Yu. V. Popov & T. K. Korchagina. (2020) Synthesis and Pharmacological Activity of 3-Phenoxybenzoic Acid Derivatives. Pharmaceutical Chemistry Journal 54:3, pages 229-235.
Crossref
Crossref
Liliana C. Baptista, Yi Sun, Christy S. Carter & Thomas W. Buford. (2020) Crosstalk Between the Gut Microbiome and Bioactive Lipids: Therapeutic Targets in Cognitive Frailty. Frontiers in Nutrition 7.
Crossref
Crossref
Yuanying Fang, Shaokun Zhang, Wenting Wu, Yanhua Liu, Juan Yang, Yuyuan Li, Min Li, Huanhuan Dong, Yi Jin, Ronghua Liu & Zunhua Yang. (2020) Design and synthesis of tetrahydropyridopyrimidine derivatives as dual GPR119 and DPP-4 modulators. Bioorganic Chemistry 94, pages 103390.
Crossref
Crossref
Alain Veilleux, Vincenzo Di Marzo & Cristoforo Silvestri. (2019) The Expanded Endocannabinoid System/Endocannabinoidome as a Potential Target for Treating Diabetes Mellitus. Current Diabetes Reports 19:11.
Crossref
Crossref
Pedro de Sena M. Pinheiro, Daniel A. Rodrigues, Rodolfo do Couto Maia, Sreekanth Thota & Carlos A.M. Fraga. (2019) The Use of Conformational Restriction in Medicinal Chemistry. Current Topics in Medicinal Chemistry 19:19, pages 1712-1733.
Crossref
Crossref
A. A. Spasov, A. N. Geisman, V. A. Kosolapov, D. A. Babkov, A. I. Rashchenko, V. A. Babkova, O. Yu. Zakhar’yashcheva & A. A. Ozerov. (2019) Synthesis and Antiglycation Activity of Novel S-Carboxyalkyl Derivatives of 2-Thiouracil. Pharmaceutical Chemistry Journal 53:7, pages 610-615.
Crossref
Crossref
Tae Hun Song, Sang Don Lee, Young Eun Ha, Kyung Jin Choi, Sang Hyun Lee, Young-Hoon Kim, Kwee Hyun Suh & Young-Jin Chun. (2019) HM47118A, a novel insulinotropic GPR119 agonist and potential oral antidiabetic agent. Diabetes Research and Clinical Practice.
Crossref
Crossref
Aman Chandra Kaushik, Ajay Kumar, Ashfaq Ur Rehman, Muhammad Junaid, Abbas Khan, Shiv Bharadwaj, Shakti Sahi & Dong-Qing Wei. (2018) Deciphering G-Protein-Coupled Receptor 119 Agonists as Promising Strategy against Type 2 Diabetes Using Systems Biology Approach. ACS Omega 3:12, pages 18214-18226.
Crossref
Crossref
Ainhoa NietoVirneliz Fernández-VegaTimothy P. SpicerEmmanuel SturchlerPramisha AdhikariNicole KennedySean MandatPeter ChaseLouis ScampaviaThomas BannisterPeter HodderPatricia H. McDonald. (2018) Identification of Novel, Structurally Diverse, Small Molecule Modulators of GPR119. ASSAY and Drug Development Technologies 16:5, pages 278-288.
Crossref
Crossref
Clifford J Bailey & Caroline Day. (2018) Treatment of type 2 diabetes: future approaches. British Medical Bulletin 126:1, pages 123-137.
Crossref
Crossref
博 李. (2018) Progress in Hypoglycemic and Lipid-Lowering Drugs. Journal of Comparative Chemistry 02:04, pages 142-160.
Crossref
Crossref
Saumitra Sengupta & Goverdhan Mehta. (2018) Natural products as modulators of the cyclic-AMP pathway: evaluation and synthesis of lead compounds. Organic & Biomolecular Chemistry 16:35, pages 6372-6390.
Crossref
Crossref
Shanta J .Persaud. (2017) Islet G-protein coupled receptors: therapeutic potential for diabetes. Current Opinion in Pharmacology 37, pages 24-28.
Crossref
Crossref
Hyojin Kim, Suk Joon Cho, Minjin Yoo, Seung Kyu Kang, Kwang Rok Kim, Hwan Hee Lee, Jin Sook Song, Sang Dal Rhee, Won Hoon Jung, Jin Hee Ahn, Jae-Kyung Jung & Kwan-Young Jung. (2017) Synthesis and biological evaluation of thiazole derivatives as GPR119 agonists. Bioorganic & Medicinal Chemistry Letters 27:23, pages 5213-5220.
Crossref
Crossref
Michael A. Kalwat & Melanie H. Cobb. (2017) Mechanisms of the amplifying pathway of insulin secretion in the β cell. Pharmacology & Therapeutics 179, pages 17-30.
Crossref
Crossref
Tomoaki Koshizawa, Toshiharu Morimoto, Gen Watanabe, Toshiaki Watanabe, Nao Yamasaki, Yoshikazu Sawada, Tomoaki Fukuda, Ayumu Okuda, Kimiyuki Shibuya & Tadaaki Ohgiya. (2017) Optimization of a novel series of potent and orally bioavailable GPR119 agonists. Bioorganic & Medicinal Chemistry Letters 27:15, pages 3249-3253.
Crossref
Crossref
Yi Huan, Qian Jiang, Gang Li, Guoliang Bai, Tian Zhou, Shuainan Liu, Caina Li, Quan Liu, Sujuan Sun, Miaomiao Yang, Nan Guo, Xing Wang, Shusen Wang, Yaojuan Liu, Guanqiao Wang, Haihong Huang & Zhufang Shen. (2017) The dual DPP4 inhibitor and GPR119 agonist HBK001 regulates glycemic control and beta cell function ex and in vivo. Scientific Reports 7:1.
Crossref
Crossref
Cheng Zhu, Liping Wang, Yuping Zhu, Zack Zhiqiang Guo, Ping Liu, Zhiyong Hu, Jason W. Szewczyk, Ling Kang, Gary Chicchi, Anka Ehrhardt, Andrea Woods, Toru Seo, Morgan Woods, Margaret van Heek, Karen H. Dingley, Jianmei Pang, Gino M. Salituro, Joyce Powell, Jenna L. Terebetski, Viktor Hornak, Louis-Charles Campeau, Robert K. Orr, Feroze Ujjainwalla, Michael Miller, Andrew Stamford, Harold B. Wood, Timothy Kowalski, Ravi P. Nargund & Scott D. Edmondson. (2017) Discovery of phenyl acetamides as potent and selective GPR119 agonists. Bioorganic & Medicinal Chemistry Letters 27:5, pages 1124-1128.
Crossref
Crossref
Clifford J. Bailey. 2017. Textbook of Diabetes. Textbook of Diabetes
1000
1011
.
Yuanying Fang, Zunhua Yang, Shankariah Gundeti, Jongkook Lee & Haeil Park. (2017) Novel 5-nitropyrimidine derivatives bearing endo-azabicyclic alcohols/amines as potent GPR119 agonists. Bioorganic & Medicinal Chemistry 25:1, pages 254-260.
Crossref
Crossref
Richard T. Matsuoka, Eric E. Boros, Andrew D. Brown, Kae M. Bullock, Will L. Canoy, Andrew J. Carpenter, Jeremy D. Cobb, Shannon E. Condon, Nicole M. Deschamps, Vassil I. Elitzin, Greg Erickson, Jing M. Fang, David H. Igo, Biren K. Joshi, Istvan W. Kaldor, Mark B. Mitchell, Gregory E. Peckham, Daniel W. Reynolds, Matthew C. Salmon, Matthew J. Sharp, Elie A. Tabet, Jennifer F. Toczko, Lianming Michael Wu & Xiao-ming M. Zhou. (2016) Development of Large-Scale Routes to Potent GPR119 Receptor Agonists. Organic Process Research & Development 20:8, pages 1469-1475.
Crossref
Crossref
Eun-Young Park, Eung-Hwi Kim, Chul-Young Kim, Mi-Hwi Kim, Jin-Seung Choung, Yoon-Sin Oh, Hong-Sub Moon & Hee-Sook Jun. (2016) Angelica dahurica Extracts Improve Glucose Tolerance through the Activation of GPR119. PLOS ONE 11:7, pages e0158796.
Crossref
Crossref
Jonathan E. Wilson, Ravi Kurukulasuriya, Christopher Sinz, Matthew Lombardo, Kate Bender, Dann Parker, Edward C. Sherer, Melissa Costa, Karen Dingley, Xiaofang Li, Stanley Mitelman, Sharon Tong, Randal Bugianesi, Anka Ehrhardt, Birgit Priest, Kevin Ratliff, Feroze Ujjainwalla, Ravi Nargund, William K. Hagmann & Scott Edmondson. (2016) Discovery and development of benzo-[1,2,4]-triazolo-[1,4]-oxazepine GPR142 agonists for the treatment of diabetes. Bioorganic & Medicinal Chemistry Letters 26:12, pages 2947-2951.
Crossref
Crossref
Kurt Ritter, Christian Buning, Nis Halland, Christoph Pöverlein & Lothar Schwink. (2015) G Protein-Coupled Receptor 119 (GPR119) Agonists for the Treatment of Diabetes: Recent Progress and Prevailing Challenges. Journal of Medicinal Chemistry 59:8, pages 3579-3592.
Crossref
Crossref
Clifford J Bailey, Abd A Tahrani & Anthony H Barnett. (2016) Future glucose-lowering drugs for type 2 diabetes. The Lancet Diabetes & Endocrinology 4:4, pages 350-359.
Crossref
Crossref
Brian M. Moran, Peter R. Flatt & Aine M. McKillop. (2016) G protein-coupled receptors: signalling and regulation by lipid agonists for improved glucose homoeostasis. Acta Diabetologica 53:2, pages 177-188.
Crossref
Crossref
Patrice D. Cani, Hubert Plovier, Matthias Van Hul, Lucie Geurts, Nathalie M. Delzenne, Céline Druart & Amandine Everard. (2015) Endocannabinoids — at the crossroads between the gut microbiota and host metabolism. Nature Reviews Endocrinology 12:3, pages 133-143.
Crossref
Crossref
Daryl Hodge, Leslie L. Glass, Eleftheria Diakogiannaki, Ramona Pais, Carol Lenaghan, David M. Smith, Marianne Wedin, Mohammad Bohlooly-Y, Fiona M. Gribble & Frank Reimann. (2016) Lipid derivatives activate GPR119 and trigger GLP-1 secretion in primary murine L-cells. Peptides 77, pages 16-20.
Crossref
Crossref
Ola Fjellström, Niklas Larsson, Shin-ichiro Yasuda, Takuma Tsuchida, Takahiro Oguma, Anna Marley, Charlotte Wennberg-Huldt, Daniel Hovdal, Hajime Fukuda, Yukimi Yoneyama, Kazuyo Sasaki, Anders Johansson, Sara Lundqvist, Johan Brengdahl, Richard J. Isaacs, Daniel Brown, Stefan Geschwindner, Lambertus Benthem, Claire Priest & Andrew Turnbull. (2015) Novel Zn2+ Modulated GPR39 Receptor Agonists Do Not Drive Acute Insulin Secretion in Rodents. PLOS ONE 10:12, pages e0145849.
Crossref
Crossref
Xing Dai, Andrew Stamford, Hong Liu, Bernard Neustadt, Jingsong Hao, Tim Kowalski, Brian Hawes, Xiaoying Xu, Hana Baker, Kim O’Neill, Morgan Woods, Huadong Tang & William Greenlee. (2015) Discovery of the oxazabicyclo[3.3.1]nonane derivatives as potent and orally active GPR119 agonists. Bioorganic & Medicinal Chemistry Letters 25:22, pages 5291-5294.
Crossref
Crossref
Adam L. Martin, Michael A. Steurer & Robert S. Aronstam. (2015) Constitutive Activity among Orphan Class-A G Protein Coupled Receptors. PLOS ONE 10:9, pages e0138463.
Crossref
Crossref
Chisayo Kozuka, Sumito Sunagawa, Rei Ueda, Moritake Higa, Yuzuru Ohshiro, Hideaki Tanaka, Chigusa Shimizu-Okabe, Chitoshi Takayama, Masayuki Matsushita, Masato Tsutsui, Shogo Ishiuchi, Masanori Nakata, Toshihiko Yada, Jun-ichi Miyazaki, Seiichi Oyadomari, Michio Shimabukuro & Hiroaki Masuzaki. (2015)
A novel insulinotropic mechanism of whole grain-derived γ-oryzanol via the suppression of local dopamine D
2
receptor signalling in mouse islet
. British Journal of Pharmacology 172:18, pages 4519-4534.
Crossref
Crossref
J. Daniel Hothersall, Charlotte E. Bussey, Alastair J. Brown, James S. Scott, Ian Dale & Philip Rawlins. (2015) Sustained wash-resistant receptor activation responses of GPR119 agonists. European Journal of Pharmacology 762, pages 430-442.
Crossref
Crossref
Ping Liu, Zhiyong Hu, Byron G. DuBois, Christopher R. Moyes, David N. Hunter, Cheng Zhu, Nam Fung Kar, Yuping Zhu, Joie Garfunkle, Ling Kang, Gary Chicchi, Anka Ehrhardt, Andrea Woods, Toru Seo, Morgan Woods, Margaret van Heek, Karen H. Dingley, Jianmei Pang, Gino M. Salituro, Joyce Powell, Jenna L. Terebetski, Viktor Hornak, Louis-Charles Campeau, Joe Lamberson, Fez Ujjainwalla, Michael Miller, Andrew Stamford, Harold B. Wood, Timothy Kowalski, Ravi P. Nargund & Scott D. Edmondson. (2015) Design of Potent and Orally Active GPR119 Agonists for the Treatment of Type II Diabetes. ACS Medicinal Chemistry Letters 6:8, pages 936-941.
Crossref
Crossref
Amarjit Singh, James Falabella, Thomas L LaPorte & Animesh Goswami. (2015)
Enzymatic Process for
N
-Substituted (3
S
)- and (3
R
)-3-Hydroxypyrrolidin-2-ones
. Organic Process Research & Development 19:7, pages 819-830.
Crossref
Crossref
David Ho, Xin Zhao, Lin Yan, Chujun Yuan, Haihong Zong, Dorothy E. Vatner, Jeffery E. Pessin & Stephen F. Vatner. (2015) Adenylyl Cyclase Type 5 Deficiency Protects Against Diet-Induced Obesity and Insulin Resistance. Diabetes 64:7, pages 2636-2645.
Crossref
Crossref
Hena Khanam & Shamsuzzaman. (2015) Bioactive Benzofuran derivatives: A review. European Journal of Medicinal Chemistry 97, pages 483-504.
Crossref
Crossref
Jeffrey Gagnon, Laurie L. Baggio, Daniel J. Drucker & Patricia L. Brubaker. (2015) Ghrelin Is a Novel Regulator of GLP-1 Secretion. Diabetes 64:5, pages 1513-1521.
Crossref
Crossref
Tomoaki Koshizawa, Yukiyoshi Yamazaki, Tadaaki Ohgiya & Kimiyuki Shibuya. (2015) A facile method for converting alcohol to thioether and its application in the synthesis of a novel GPR119 agonist. Tetrahedron 71:21, pages 3231-3236.
Crossref
Crossref
Rieko Takano, Masao Yoshida, Masahiro Inoue, Takeshi Honda, Ryutaro Nakashima, Koji Matsumoto, Tatsuya Yano, Tsuneaki Ogata, Nobuaki Watanabe, Masakazu Hirouchi, Tomoko Yoneyama, Shuichiro Ito & Narihiro Toda. (2015) Discovery of DS-1558: A Potent and Orally Bioavailable GPR40 Agonist. ACS Medicinal Chemistry Letters 6:3, pages 266-270.
Crossref
Crossref
Andrew J. Krentz, Lutz Heinemann & Marcus Hompesch. 2015. Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development. Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development
45
69
.
M S Engelstoft, C Norn, M Hauge, N D Holliday, L Elster, J Lehmann, R M Jones, T M Frimurer & T W Schwartz. (2014)
Structural basis for constitutive activity and agonist‐induced activation of the enteroendocrine fat sensor
GPR
119
. British Journal of Pharmacology 171:24, pages 5774-5789.
Crossref
Crossref
Mihai Azimioara, Phil Alper, Christopher Cow, Daniel Mutnick, Victor Nikulin, Gerald Lelais, John Mecom, Matthew McNeill, Pierre-Yves Michellys, Zhiliang Wang, Esther Reding, Michael Paliotti, Jing Li, Dingjiu Bao, Jocelyn Zoll, Young Kim, Matthew Zimmerman, Todd Groessl, Tove Tuntland, Sean B. Joseph, Peter McNamara, H. Martin Seidel & Robert Epple. (2014) Novel tricyclic pyrazolopyrimidines as potent and selective GPR119 agonists. Bioorganic & Medicinal Chemistry Letters 24:23, pages 5478-5483.
Crossref
Crossref
Xiang-Yang Ye, Christian L. Morales, Ying Wang, Karen A. Rossi, Sarah E. Malmstrom, Mojgan Abousleiman, Larisa Sereda, Atsu Apedo, Jeffrey A. Robl, Keith J. Miller, John Krupinski & Dean A. Wacker. (2014) Synthesis and structure–activity relationship of dihydrobenzofuran derivatives as novel human GPR119 agonists. Bioorganic & Medicinal Chemistry Letters 24:11, pages 2539-2545.
Crossref
Crossref
Tae-Young Ha, Young-Seok Kim, Chun Hwa Kim, Hyo-Sun Choi, Jin Yang, Soo Hyun Park, Dae Hoon Kim & Jae-Keol Rhee. (2013) Novel GPR119 agonist HD0471042 attenuated type 2 diabetes mellitus. Archives of Pharmacal Research 37:5, pages 671-678.
Crossref
Crossref
Derek J. Nunez, Mark A. Bush, David A. Collins, Susan L. McMullen, Dawn Gillmor, Glen Apseloff, George Atiee, Leonor Corsino, Linda Morrow & Paul L. Feldman. (2014) Gut Hormone Pharmacology of a Novel GPR119 Agonist (GSK1292263), Metformin, and Sitagliptin in Type 2 Diabetes Mellitus: Results from Two Randomized Studies. PLoS ONE 9:4, pages e92494.
Crossref
Crossref
Brian M. Moran, Yasser H.A. Abdel-Wahab, Peter R. Flatt & Aine M. McKillop. (2014) Activation of GPR119 by fatty acid agonists augments insulin release from clonal β-cells and isolated pancreatic islets and improves glucose tolerance in mice. Biological Chemistry 395:4, pages 453-464.
Crossref
Crossref
Yan-Wei Hu, Jun-Yao Yang, Xin Ma, Zhi-Ping Chen, Ya-Rong Hu, Jia-Yi Zhao, Shu-Fen Li, Yu-Rong Qiu, Jing-Bo Lu, Yan-Chao Wang, Ji-Juan Gao, Yan-Hua Sha, Lei Zheng & Qian Wang. (2014) A lincRNA-DYNLRB2-2/GPR119/GLP-1R/ABCA1-dependent signal transduction pathway is essential for the regulation of cholesterol homeostasis. Journal of Lipid Research 55:4, pages 681-697.
Crossref
Crossref
Kenjiro Sato, Hiromichi Sugimoto, Kentaro Rikimaru, Hiroshi Imoto, Masahiro Kamaura, Nobuyuki Negoro, Yoshiyuki Tsujihata, Hirohisa Miyashita, Tomoyuki Odani & Toshiki Murata. (2014) Discovery of a novel series of indoline carbamate and indolinylpyrimidine derivatives as potent GPR119 agonists. Bioorganic & Medicinal Chemistry 22:5, pages 1649-1666.
Crossref
Crossref
Kimiyuki Shibuya, Tomoaki Koshizawa, Hayato Hosoi, Gen Watanabe, Toshiharu Morimoto & Tadaaki Ohgiya. (2014) A Practical Synthesis of (4-(Spiro[chromane-2,4'-piperidin]-6-yl)phenyl)methanol as a Key Intermediate of Novel GPR119 Agonist. HETEROCYCLES 89:7, pages 1632.
Crossref
Crossref
Xiu-Lei Mo, Zhao Yang & Ya-Xiong Tao. 2014. Glucose Homeostatis and the Pathogenesis of Diabetes Mellitus. Glucose Homeostatis and the Pathogenesis of Diabetes Mellitus
95
131
.
Sang-Uk Kang. (2013) GPR119 agonists: a promising approach for T2DM treatment? A SWOT analysis of GPR119. Drug Discovery Today 18:23-24, pages 1309-1315.
Crossref
Crossref
Boon Chin Heng, Dominique Aubel & Martin Fussenegger. (2013) An overview of the diverse roles of G-protein coupled receptors (GPCRs) in the pathophysiology of various human diseases. Biotechnology Advances 31:8, pages 1676-1694.
Crossref
Crossref
Dong-Soon Im. (2013) Intercellular Lipid Mediators and GPCR Drug Discovery. Biomolecules and Therapeutics 21:6, pages 411-422.
Crossref
Crossref
Uta Lessel. 2013. De novo Molecular Design. De novo Molecular Design
349
371
.
Narihiro Toda, Xiaolin Hao, Yasuyuki Ogawa, Kozo Oda, Ming Yu, Zice Fu, Yi Chen, Yongjae Kim, Mike Lizarzaburu, Sarah Lively, Shauna Lawlis, Michiko Murakoshi, Futoshi Nara, Nobuaki Watanabe, Jeff D. Reagan, Hui Tian, Angela Fu, Alykhan Motani, Qingxiang Liu, Yi-Jyun Lin, Run Zhuang, Yumei Xiong, Peter Fan, Julio Medina, Leping Li, Masanori Izumi, Ryo Okuyama & Satoshi Shibuya. (2013) Potent and Orally Bioavailable GPR142 Agonists as Novel Insulin Secretagogues for the Treatment of Type 2 Diabetes. ACS Medicinal Chemistry Letters 4:8, pages 790-794.
Crossref
Crossref
Arturo D. Mancini & Vincent Poitout. (2013) Les récepteurs membranaires des acides gras de la cellule β. médecine/sciences 29:8-9, pages 715-721.
Crossref
Crossref
W. Gattrell, C. Johnstone, S. Patel, C. Sambrook Smith, A. Scheel & M. Schindler. (2013) Designed multiple ligands in metabolic disease research: from concept to platform. Drug Discovery Today 18:15-16, pages 692-696.
Crossref
Crossref
Etzer Darout, Ralph P. Robinson, Kim F. McClure, Matthew Corbett, Bryan Li, Andrei Shavnya, Melissa P. Andrews, Christopher S. Jones, Qifang, Li, Martha L. Minich, Vincent Mascitti, Cristiano R. W. Guimarães, Michael J. Munchhof, Kevin B. Bahnck, Cuiman Cai, David A. Price, Spiros Liras, Paul D. Bonin, Peter Cornelius, Ruduan Wang, Victoria Bagdasarian, Colleen P. Sobota, Sam Hornby, Victoria M. Masterson, Reena M. Joseph, Amit S. Kalgutkar & Yue Chen. (2012) Design and Synthesis of Diazatricyclodecane Agonists of the G-Protein-Coupled Receptor 119. Journal of Medicinal Chemistry 56:1, pages 301-319.
Crossref
Crossref
Bernd Wellenzohn, Uta Lessel, Andreas Beller, Timo Isambert, Christoph Hoenke & Bernd Nosse. (2012) Identification of New Potent GPR119 Agonists by Combining Virtual Screening and Combinatorial Chemistry. Journal of Medicinal Chemistry 55:24, pages 11031-11041.
Crossref
Crossref
Amedeo Vetere & Bridget K. Wagner. (2012) Chemical Methods to Induce Beta-Cell Proliferation. International Journal of Endocrinology 2012, pages 1-8.
Crossref
Crossref